According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ1.25. In 2022 the company made an earnings per share (EPS) of -ยฃ1.57 a decrease over its 2021 EPS that were of ยฃ2.75.